Daptica is contraindicated for use in type 1 diabetes. Daptica is not indicated for the use in weight control programmes and not indicated for the treatment of any other conditions except type 2 diabetes. Kindly refer to the Daptica Professional Information for full prescribing information, contraindications, warnings, special precautions and interactions.
Daptica is marketed and sold by Activo Health (Pty) Ltd and is distributed nationally by Imperial Health Sciences (IHS). Product and/or sales enquiries can be directed to firstname.lastname@example.org or +27 12 848 7600.
Also available in 5mg: